Medifocus, Inc. MDFZF Company Overview Stock Message

New Post Public Reply Private Reply Replies (0) Message Board

Sep 14, 2013 at 12:56 AM

Medifocus, Inc. MDFZF Company Overview

Stock Message Board http://investorshangout.com/search?q=MDFZF&am...mp;yt1=Go!

Medifocus, Inc. MDFZF Current Price and Quotes
Last Price 0.151
Previous Close 0.151 Open N/A
Daily Range N/A - N/A 52wk Range 0.305 - 0.08
Volume 0 Dividend N/A
Average Vol (3m) 17,058 Yield N/A
Medifocus, Inc. MDFZF

Company Verified Profile
Company Information

The Exchange Tower, PO Box 427
130 King Street West, Suite 1800
Toronto, ONT M5X 1E3
Canada

Website: http://www.medifocusinc.com
Phone: 410-290-5734
Find us on:

Medifocus, Inc. MDFZF
Medifocus, Inc. (TSXV-MFS, OTC-MDFZF) is a leader in the use of focused microwave energy to treat cancer and other tumors. It owns two fully developed technology platforms with comprehensive US and international patent protection: (1) The Endo-thermotherapy Platform-a catheter-basis focused heat technology platform that utilizes natural body openings to deliver precise microwave thermotherapy to the diseased sites. The U.S. FDA approved Prolieve Thermodilatation System for the treatment of Beni...

Medifocus, Inc. MDFZF
Financial Reportings and Disclosures

Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Jun 30, 2013 Interim Financial Report
Fiscal Year End 3/31
OTC Marketplace OTCQX International
Profile Data

SIC - Industry Classification 3845 - Electromedical equipment
Incorporated In: Canada
Year of Inc. 2008
Employees 29 a/o Aug 30, 2013
Company Officers/Contacts

Dr. Augustine Y Cheung, PhD CEO
John Mon COO, IR
Mirsad Jakubovic CFO
Douglas Liu Director, Bus. Dev.
Company Directors

Grant B. Walsh Chairman
Joseph S.C. Chan
Gus Chow
Ernie Eves
Service Providers

DAD/PAL
Scarsdale Equities LLC
10 Rockefeller Plaza
Suite 720
New York, NY, 10020
United States

Auditor/Accountant
Sievert & Sawrantschuck LLP
43 Colbourne Street. PH
Toronto, ONT, M5E 1E3
Canada

T. Robert Hambley
151 Bloor Street West, Suite 800
Royal Bank Plaza. South Tower
Toronto, ONT, M5S 1S4
Canada

Legal Counsel
Norton Rose OR LLP
Suite 3800, Royal Bank Plaza, South Tower
Toronto, ONT, M5J 2Z4
Canada

Investor Relations Firm
Consulting for Strategic Growth 1, Ltd.
880 Third Ave.
New York, NY, 10022
United States

Medifocus, Inc. MDFZF
MDFZF Security Details

Share Structure

Market Value1 $17,706,391 a/o Sep 13, 2013
Shares Outstanding 117,260,870 a/o Aug 28, 2013
Float 24,337,335 a/o Apr 30, 2011
Authorized Shares Unlimited a/o Jun 30, 2011
Par Value No Par Value
Shareholders

Shareholders of Record Not Available
Non US Stock Exchange Listing

MFS - TSX Venture Exchange - Qualified
Short Selling Data

Short Interest 545 (0%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Equity Transfer & Trust Company

Medifocus, Inc. MDFZF Recent News

Aug 29, 2013 Medifocus, Inc. Announces Revenue and Results of Operations for Fiscal First Quarter 2014
Aug 12, 2013 John Mon, COO of Medifocus, Inc., Is Featured in an Audio Interview on Princeton Research's Money Info Show Hosted by Bill Chippas and Charles Moskowitz
Aug 9, 2013 / CORRECTION - Medifocus, Inc. Announces the Initiation of Its Principal Investigational Site in Canada for Its Pivotal Phase III Clinical Trial for Breast Cancer Treatment
Aug 9, 2013 / CORRECTION-Medifocus, Inc. Announces the Initiation of Its Principal Investigational Site in Canada for Its Pivotal Phase III Clinical Trial for Breast Cancer Treatment
Aug 9, 2013 Medifocus, Inc. Announces the Initiation of Its Principal Investigational Site in Canada for Its Pivotal Phase III Clinical Trial for Breast Cancer Treatment
Aug 1, 2013 John Mon, COO of Medifocus, Inc., is Featured in a New Audio Interview at SmallCapVoice.com
Jul 31, 2013 Medifocus, Inc. Obtains New US Patent Covering the Use of Heat for the Controlled Release/Activation of Drugs and Genes
Jul 30, 2013 Medifocus Inc. Announces Revenues for Year Ended March, 2013 and Adjustment of Prior Period Accounting Error
Jul 24, 2013 Medifocus, Inc. Enlists Maxim Group as Financial Advisor and Investment Banker
Jul 9, 2013 Medifocus, Inc. Announces DTC Eligibility of Its Common Stock

Medifocus, Inc. MDFZF Financials
Period Ending Mar 31, 2013 Mar 31, 2012
Total Revenue 1,775 -
Cost of Revenue 968 -
Gross Profit 807 -
Operating Expenses

Research and Development 1,420 599
Sales, General and Admin. 4,801 795
Non-Recurring Items - -
Other 7 6
Operating Income (5,420) (1,400)
Income From Continuing Operations

Add'l Income/Expense Items (133) 39
Earnings Before Interest and Tax (5,553) (1,414)
Interest Expense 175 95
Earnings Before Tax (5,728) (1,509)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (5,728) (1,456)
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (5,728) (1,456)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (5,728) (1,456)

MDFZF Medifocus, Inc. Research DD Guide

MDFZF Medifocus, Inc. Stock Message Board http://investorshangout.com/search?q=MDFZF&am...mp;yt0=Go!
MDFZF Medifocus, Inc. Stock Quote http://www.otcmarkets.com/stock/MDFZF/quote
MDFZF Medifocus, Inc. Stock Chart http://www.otcmarkets.com/stock/MDFZF/chart
MDFZF Medifocus, Inc. Company Info http://www.otcmarkets.com/stock/MDFZF/company-info
MDFZF Medifocus, Inc. Recent News http://www.otcmarkets.com/stock/MDFZF/news
MDFZF Medifocus, Inc. Financials http://www.otcmarkets.com/stock/MDFZF/financials
MDFZF Medifocus, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/MDFZF/filings
MDFZF Medifocus, Inc. Short Sales http://www.otcmarkets.com/stock/MDFZF/short-sales
MDFZF Medifocus, Inc. Insider Disclosure http://www.otcmarkets.com/stock/MDFZF/insider-transactions
MDFZF Medifocus, Inc. Research Reports http://www.otcmarkets.com/stock/MDFZF/research
MDFZF Medifocus, Inc. Summary http://finance.yahoo.com/q?s=MDFZF
MDFZF Medifocus, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=MDFZF+Historical+Prices
MDFZF Medifocus, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=MDFZF
MDFZF Medifocus, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=MDFZF+Basic+Chart
MDFZF Medifocus, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=MDFZF+Basic+Tech.+Analysis
MDFZF Medifocus, Inc. Headlines http://finance.yahoo.com/q/h?s=MDFZF+Headlines
MDFZF Medifocus, Inc. Press Releases http://finance.yahoo.com/q/p?s=MDFZF+Press+Releases
MDFZF Medifocus, Inc. Company Profile http://finance.yahoo.com/q/pr?s=MDFZF+Profile
MDFZF Medifocus, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=MDFZF+Key+Statistics
MDFZF Medifocus, Inc. Industry http://finance.yahoo.com/q/in?s=MDFZF+Industry
MDFZF Medifocus, Inc. Major Holders http://finance.yahoo.com/q/mh?s=MDFZF+Major+Holders
MDFZF Medifocus, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=MDFZF+Insider+Transactions
MDFZF Medifocus, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=MDFZF+Insider+Roster
MDFZF Medifocus, Inc. Income Statement http://finance.yahoo.com/q/is?s=MDFZF
MDFZF Medifocus, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=MDFZF
MDFZF Medifocus, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=MDFZF+Cash+Flow&annual
MDFZF Medifocus, Inc. Nasdaq http://www.nasdaq.com/symbol/MDFZF
MDFZF Medifocus, Inc. Market Watch http://www.marketwatch.com/investing/stock/MDFZF
MDFZF Medifocus, Inc. Bloomberg http://www.bloomberg.com/quote/MDFZF:US
MDFZF Medifocus, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=MDFZF
MDFZF Medifocus, Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=MDFZF
MDFZF Medifocus, Inc. Barchart http://www.barchart.com/quotes/stocks/MDFZF
MDFZF Medifocus, Inc. OTC Short Report http://otcshortreport.com/index.php?index=MDFZF
MDFZF Medifocus, Inc. Investopedia http://www.investopedia.com/markets/stocks/MDFZF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...